STRS Ohio’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-4,400
Closed -$235K 2124
2016
Q1
$235K Sell
4,400
-4,300
-49% -$317K ﹤0.01% 1479
2015
Q4
$982K Hold
8,700
﹤0.01% 818
2015
Q3
$1.02M Sell
8,700
-7,200
-45% -$940K ﹤0.01% 812
2015
Q2
$1.23M Buy
15,900
+4,100
+35% +$269K 0.01% 738
2015
Q1
$682K Sell
11,800
-3,600
-23% -$153K ﹤0.01% 1062
2014
Q4
$497K Hold
15,400
﹤0.01% 1207
2014
Q3
$377K Buy
15,400
+900
+6% +$18.3K ﹤0.01% 1294
2014
Q2
$257K Buy
14,500
+2,100
+17% +$33.8K ﹤0.01% 1406
2014
Q1
$248K Buy
+12,400
New +$240K ﹤0.01% 1379

Other funds holding ANAC

STRS Ohio's ANAC Position: Q2 2016 in Review

STRS Ohio sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 4,400 shares — an estimated $235K sold.

STRS Ohio first reported a position in ANAC in Q1 2014 and held it in 9 quarters. The position peaked at $1.23M in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • STRS Ohio reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • STRS Ohio sold 4,400 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $235K.
  • STRS Ohio first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 9 quarters.
  • STRS Ohio's ANACOR PHARMACEUTICALS INC COM position peaked at $1.23M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on STRS Ohio's 13F filing for Q2 2016, filed 26 Jul 2016.